Skip to main content

Table 1 Characteristics of treatment and placebo group

From: A randomized, double-blind, placebo-controlled trial on the role of preemptive analgesia with acetaminophen [paracetamol] in reducing headache following electroconvulsive therapy [ECT]

Variable

(Acetaminophen) Paracetamol

Placebo

P value

Age

18-40 yrs

24

26

0.71a

41-60 yrs

28

27

0.85a

>60 yrs

11

10

0.81a

Sex

Male

21

31

0.07a

Female

42

32

Marital status

Married

28

29

0.60a

Single

35

34

Number of patients use alcohol

Alcohol dependent patients

5

4

0.15b

Alcohol misuse patients

9

18

Number of patients do not use alcohol

49

41

Diagnosis

Depression

32

22

0.07a

Bipolar affective disorder

17

22

0.33a

Schizophrenia with secondary depression.

14

19

0.46a

Clinical Parameters

Comorbid medical illness

19

14

0.31a

Migraine

4

5

1.00b

Headache during this episode

4

7

0.52b

ECT-related parameters.

Seizure duration Median (IQR)

20 (15–30)

20 (15–30)

0.94c

Energy level Median (IQR)

10 (5–10)

10 (10–10)

<0.01c

  1. achi-square test, bFishers exact test, cMann Whitney U test; IQR Interquartile range